News | August 18, 2011

U-Systems Receives Health Canada Approval For Ultrasound Breast Cancer Screening

U-Systems Receives Health Canada Approval For  Ultrasound Breast Cancer Screening

August 18, 2011 U-Systems announced that it has been granted a medical device license by the Medical Devices Bureau of Health Canada to sell and market the somo•v automated breast ultrasound (ABUS) system as an adjunct to mammography for screening asymptomatic women for breast cancer in Canada.  Approval was based on extensive clinical evidence and includes the following indication: “The somo•v ABUS ultrasound device is intended for use as an adjunct to mammography to provide physicians with an increase in the sensitivity of breast cancer detection in diagnostic symptomatic and screening asymptomatic women.”  

The somo•v ABUS system is the only ultrasound device approved for breast cancer screening by Health Canada, the agency responsible for assessing medical device safety, effectiveness and quality  in Canada.  The somo•v ABUS system is also the only ultrasound device approved for breast cancer screening in the 27 European Union countries. In the United States, the somo•v ABUS system is cleared by the Food & Drug Administration (FDA) for adjunctive diagnostic use with mammography.

“With this approval from Health Canada, we are proud to make this critical screening tool available to improve the early detection of breast cancer in Canada,” said Ron Ho, president and CEO of U-Systems.  “The somo•v Automated Breast Ultrasound System is not intended as a replacement for mammography.  However, there is a growing body of scientific evidence that supplementing mammography with ultrasound detects more cancers than mammography alone.”

Using proprietary technology to automate the breast ultrasound imaging process, the U-Systems’ somo•v ABUS is ideally suited for the high-volume, screening environment.  The somo•viewer Advanced 3-D Workstation enables fast review and archive of patient exams, optimizing breast ultrasound screening workflow.

U-Systems is also the sponsor of the national SOMO•INSIGHT Clinical Study, which is designed to evaluate whether digital mammography in combination with somo•v ABUS is more sensitive than a routine screening mammogram alone in detecting breast cancer in women with dense breast tissue. More than 15,000 women have participated in the study, which is actively recruiting up to 20,000 women at multiple breast imaging centers nationwide. To date, the study has identified a significant number of mammographically negative breast cancers that were subsequently detected by ABUS.

For more information: www.u-systems.com

 

Related Content

Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership With EmCyte Corp.
News | Ultrasound Imaging | June 12, 2019
Konica Minolta Healthcare announced a new autologous biologics workshop in partnership with EmCyte Corp. The workshop...
Civco Launches Envision Ultrasound Viral Barriers
Technology | Ultrasound Imaging | June 06, 2019
Civco Medical Solutions announced a new solution that removes gel from ultrasound procedures. Envision viral barriers...
Quantitative Transmission Ultrasound Featured at Acoustical Society of America

Fused QT Ultrasound 3-D quantitative transmission ultrasound and compounded reflection axial images showing high resolution image of internal organs, tissue, skin and hair of neo-natal piglet. Anatomy courtesy of C. Ruoff, DVM.

News | Ultrasound Imaging | May 29, 2019
May 29, 2019 — QT Ultrasound recently showcased its advanced...
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Philips Lumify Earns U.S. Army Airworthiness Certification
News | Ultrasound Imaging | May 22, 2019
Philips announced that Philips Lumify, a point-of-care ultrasound device, has earned the U.S. Army Airworthiness...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Clarius Releases Clarius Live Ultrasound Telemedicine Solution
Technology | Ultrasound Imaging | May 15, 2019
Clarius Mobile Health released a telemedicine solution called Clarius Live. The simple-to-use feature allows any...
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...
Hong Kong Polytechnic University Develops Palm-sized 3-D Scoliosis Ultrasound Imaging System
News | Ultrasound Imaging | May 03, 2019
The Hong Kong Polytechnic University (PolyU) announced the development of a palm-sized 3-D ultrasound imaging system...